|
We have detected that your browser blocked our video player.
Please enable popups and try again. Thank you.
Late Breaker Track B: Clinical Treatment and Care Track 7/25/2007
International AIDS Society and Australasian Society for HIV Medicine, Sydney, Australia
|
|
|
Late Breaker Track B - Session 1
|
 |
|
|
 |
For more information on this session, please see the conference Programme-at-a-Glance page.
Speakers for this session:
|
| |
 Video
|
| |
| |
Video
|
 Abstract
|
| |
| |
Efficacy and Safety of NRTI´s Switch to Tenofovir Plus Emtricitabine (Truvada(R)) vs. Abacavir Plus Lamivudine (Kivexa(R)) in Patients with Virologic Suppression Receiving a Lamivudine Containing HAART: The BICOMBO Study
Jose Gatell, M.D., Ph.D. Infectious Diseases, Hospital Clinic Universitario Spain |
Video
|
Slides
|
Abstract
|
| |
| |
Antiretroviral Therapy Initiated Before 12 Weeks Of Age Reduces Early Mortality In Young HIV-Infected Infants: Evidence From The Children With HIV Early Antiretroviral Therapy (CHER) Study
Avy Violari, M.D., F.C.Peads. (SA) Paediatric Trials Coordinator
Perinatal HIV Research Unit, University of Witwatersrand South Africa |
Video
|
Slides
|
Abstract
|
| |
| |
A Multicenter, Randomized, Double-Blind, Comparative Trial Of A Novel CCR5 Antagonist, Maraviroc Versus Efavirenz, Both In Combination With Combivir (Zidovudine [ZDV]/Lamivudine [3TC]), For The Treatment Of Antiretroviral Naive Subjects Infected With R5 HI
Michael Saag, M.D. Director UAB Center for AIDS Research, University of Alabama at Birmingham United States |
Video
|
Slides
|
Abstract
|
Late Breaker Track B - Session 2
|
|
|
|
| |
For more information on this session, please see the conference Programme-at-a-Glance page.
|
|
|
 |
|
|
|
|
EMAIL ALERTS
Sign up for email alerts and stay informed about
upcoming HealthCasts, and the latest health policy issues, news and events. |
|
|
|
|
CONTACT US
Contact us by email with any comments, problems,
suggestions.
Call the kaisernetwork.org Help Desk at 202-347-5270. |
|
 |
|
|
|
|
|
